FDA Drug Recalls

Recalls / Class II

Class IID-512-2013

Product

AMBI 40PSE/400GFN/20DM, Cough Suppressant, Expectorant, Nasal Decongestant, 100 count bottle, OTC, Manufactured for: AMBI Pharmaceuticals, Brooksville, FL 34604, NDC 66870-0409-01

Affected lot / code info
Lot # 11D001 Exp. 03/13; Lot # 11D002 Exp. 03/13; Lot#11K003 Exp. 09/13; Lot# 12C010 Exp. 02/14.

Why it was recalled

CGMP Deviations: Products are underdosed or have an incorrect dosage regime.

Recalling firm

Firm
TG United, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
16275 Aviation Loop Dr, N/A, Brooksville, Florida 34604-6805

Distribution

Quantity
1772 bottles per 100 count each
Distribution pattern
FL, MS, SC, LA and TX

Timeline

Recall initiated
2013-01-30
FDA classified
2013-06-04
Posted by FDA
2013-06-12
Terminated
2016-09-30
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-512-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls